Diabetic Ketoacidosis: An Adverse Reaction to Immunotherapy

Immune checkpoint inhibitors (ICPIs), such as anti-programmed death receptor 1 (PD-1) and anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), are being utilized in the treatment of many malignancies. Just like their benefits in increasing recurrence-free survival, they also have shown numerou...

Descripción completa

Detalles Bibliográficos
Autores principales: Keerty, Dinesh, Das, Manoj, Hallanger-Johnson, Julie, Haynes, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584305/
https://www.ncbi.nlm.nih.gov/pubmed/33123445
http://dx.doi.org/10.7759/cureus.10632

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584305/
https://www.ncbi.nlm.nih.gov/pubmed/33123445
http://dx.doi.org/10.7759/cureus.10632

Ejemplares similares